Journal
JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY
Volume 43, Issue 3, Pages 351-361Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.3109/13668250.2017.1350836
Keywords
Intellectual disability; developmental disability; medication regimen complexity; primary care; polypharmacy
Categories
Ask authors/readers for more resources
Background: People with intellectual and developmental disabilities (IDD) may be at risk for medication-related problems due to complex medication regimens. The objective of this study was to determine the medication regimen complexity of adults with IDD. Methods: This retrospective study compared the Medication Regimen Complexity Index (MRCI) scores and number of medications of patients with IDD to a group without IDD (GenMed group), as well as a subanalysis between type of IDD. Results: The MRCI score of the IDD group (29.0+8.1, n=200) was significantly higher than that of the GenMed group (16.712.0, n=200), p<.001. IDD patients had significantly more medications (11.2 +/- 6.5) compared with the GenMed group (7.4 +/- 5.1), p<.001. There were no significant differences between the number of medications prescribed or the MRCI scores between types of IDD. Conclusion: Clinicians must be aware that patients who have IDD have more complex medication regimens and higher potential for medication-related problems.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available